Health Sciences Acquisiti...

NASDAQ: HSAQ · Real-Time Price · USD
13.31
2.59 (24.16%)
At close: Jan 26, 2023, 9:59 PM

Health Sciences Acquisitions 2 Revenue Breakdown

Period Ending Dec 31, 2024
Product Revenue 633K
Product Revenue Growth n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Selling, General, and Administrative Revenue 6.26M 7.86M 5.67M 6.47M 6.34M 5.32M 4.41M 756.72K 813.41K 938.17K 451.95K 83.99K 94.44K 96.32K 111.95K 179.99K 68.63K
Selling, General, and Administrative Revenue Growth -20.30% +38.69% -12.39% +1.94% +19.29% +20.56% +482.91% -6.97% -13.30% +107.58% +438.09% -11.07% -1.94% -13.96% -37.80% +162.27% n/a
Research and Development Revenue 13.48M 17.49M 11.6M 11.13M 8.56M 8.5M 8.25M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Research and Development Revenue Growth -22.93% +50.87% +4.22% +30.01% +0.69% +2.97% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a